1. Home
  2. ERC vs ALEC Comparison

ERC vs ALEC Comparison

Compare ERC & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Multi-Sector Income Fund

ERC

Allspring Multi-Sector Income Fund

HOLD

Current Price

$8.97

Market Cap

260.9M

Sector

Finance

ML Signal

HOLD

Logo Alector Inc.

ALEC

Alector Inc.

HOLD

Current Price

$2.21

Market Cap

268.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERC
ALEC
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
260.9M
268.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
ERC
ALEC
Price
$8.97
$2.21
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.83
AVG Volume (30 Days)
78.7K
524.3K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
8.37%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
N/A
$21,045,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$29.87
P/E Ratio
$12.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.72
$1.09
52 Week High
$9.78
$3.40

Technical Indicators

Market Signals
Indicator
ERC
ALEC
Relative Strength Index (RSI) 41.26 47.32
Support Level $8.90 $1.91
Resistance Level $9.33 $2.62
Average True Range (ATR) 0.12 0.15
MACD -0.02 -0.01
Stochastic Oscillator 43.75 30.22

Price Performance

Historical Comparison
ERC
ALEC

About ERC Allspring Multi-Sector Income Fund

Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

Share on Social Networks: